| Name | (2S,4R)-N-[(1S,2S)-2-chloro-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-4-ethylpiperidine-2-carboxamide |
|---|---|
| Synonyms |
Pirlimycin
UNII-LM19JT6G5K Pirlimycinum Pirlimycine Pirlimycina |
| Description | Pirlimycin (RU 38882), a lincosamide antibiotic, is active against Gram-positive bacteria. Pirlimycin acts by inhibiting bacterial protein synthesis via binding with the 50S subunit of the ribosome[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.31g/cm3 |
|---|---|
| Boiling Point | 643.9ºC at 760 mmHg |
| Molecular Formula | C17H31ClN2O5S |
| Molecular Weight | 410.96 |
| Flash Point | 343.2ºC |
| Exact Mass | 410.16400 |
| PSA | 136.35000 |
| LogP | 0.76700 |
| Index of Refraction | 1.574 |
|
~%
79548-73-5 |
| Literature: Journal of Medicinal Chemistry, , vol. 27, # 2 p. 216 - 223 |
|
~%
79548-73-5 |
| Literature: Journal of Medicinal Chemistry, , vol. 27, # 2 p. 216 - 223 |
|
~%
79548-73-5 |
| Literature: Journal of Medicinal Chemistry, , vol. 27, # 2 p. 216 - 223 |